Literature DB >> 15750077

Vi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan.

John Wain1, Deborah House, Afia Zafar, Stephen Baker, Satheesh Nair, Claire Kidgell, Zulfiqar Bhutta, Gordon Dougan, Rumina Hasan.   

Abstract

The accurate identification of Salmonella enterica subsp. enterica serovar Typhi variants that fail to express the capsular polysaccharide, Vi, is an important and much discussed issue for medical microbiology. We have tested a multiplex PCR method which shows the presence or absence of the genetic locus required for Vi expression. Of 2,222 Salmonella serovar Typhi clinical isolates collected from patients' blood over a 4-year period in a region of Pakistan where typhoid is endemic, 12 tested negative for Vi expression by serological agglutination. However, only 1 of these 12 was Vi negative by the multiplex PCR method. This result was confirmed by immunofluorescence, the most sensitive method for Vi characterization in Salmonella serovar Typhi. The multiplex PCR described therefore represents a simple and accurate method for surveillance for Vi-negative variants of Salmonella serovar Typhi in Pakistan. Testing of clinical isolates of Salmonella serovar Typhi, before subculture, from other regions where Vi-negative Salmonella serovar Typhi has been described should be carried out so that the impact of vaccination with purified Vi antigen on the levels of Vi-negative Salmonella serovar Typhi in bacterial populations can be assessed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750077      PMCID: PMC1081282          DOI: 10.1128/JCM.43.3.1158-1165.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Field effectiveness of Vi polysaccharide typhoid vaccine in the People's Republic of China.

Authors:  Subhash C Arya
Journal:  J Infect Dis       Date:  2002-03-15       Impact factor: 5.226

Review 2.  Typhoid fever: pathogenesis and immunologic control. 2.

Authors:  R B Hornick; S E Greisman; T E Woodward; H L DuPont; A T Dawkins; M J Snyder
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

3.  Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18.

Authors:  J Parkhill; G Dougan; K D James; N R Thomson; D Pickard; J Wain; C Churcher; K L Mungall; S D Bentley; M T Holden; M Sebaihia; S Baker; D Basham; K Brooks; T Chillingworth; P Connerton; A Cronin; P Davis; R M Davies; L Dowd; N White; J Farrar; T Feltwell; N Hamlin; A Haque; T T Hien; S Holroyd; K Jagels; A Krogh; T S Larsen; S Leather; S Moule; P O'Gaora; C Parry; M Quail; K Rutherford; M Simmonds; J Skelton; K Stevens; S Whitehead; B G Barrell
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

4.  Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

Authors:  Daniel R Feikin; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2002-08-07       Impact factor: 9.079

5.  Salmonella enterica serovar Typhi strains from which SPI7, a 134-kilobase island with genes for Vi exopolysaccharide and other functions, has been deleted.

Authors:  Satheesh Nair; Suneetha Alokam; Sushma Kothapalli; Steffan Porwollik; Emily Proctor; Carmen Choy; Michael McClelland; Shu-Lin Liu; Kenneth E Sanderson
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

6.  Precise excision of the large pathogenicity island, SPI7, in Salmonella enterica serovar Typhi.

Authors:  Susan M Bueno; Carlos A Santiviago; Alejandro A Murillo; Juan A Fuentes; A Nicole Trombert; Paula I Rodas; Philip Youderian; Guido C Mora
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

7.  Composition, acquisition, and distribution of the Vi exopolysaccharide-encoding Salmonella enterica pathogenicity island SPI-7.

Authors:  Derek Pickard; John Wain; Stephen Baker; Alexandra Line; Sonia Chohan; Maria Fookes; Andrew Barron; Peadar O Gaora; José A Chabalgoity; Niren Thanky; Christoph Scholes; Nicholas Thomson; Michael Quail; Julian Parkhill; Gordon Dougan
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

8.  Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old.

Authors:  Claire Kidgell; Ulrike Reichard; John Wain; Bodo Linz; Mia Torpdahl; Gordon Dougan; Mark Achtman
Journal:  Infect Genet Evol       Date:  2002-10       Impact factor: 3.342

Review 9.  Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.

Authors:  J D Robbins; J B Robbins
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

10.  The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

Authors:  F Y Lin; V A Ho; H B Khiem; D D Trach; P V Bay; T C Thanh; Z Kossaczka; D A Bryla; J Shiloach; J B Robbins; R Schneerson; S C Szu
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 176.079

View more
  19 in total

Review 1.  Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis.

Authors:  Manuela Raffatellu; Daniela Chessa; R Paul Wilson; Cagla Tükel; Mustafa Akçelik; Andreas J Bäumler
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Re: outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast.

Authors:  Subhash C Arya; Nirmala Agarwal
Journal:  Eur J Epidemiol       Date:  2006-05-23       Impact factor: 8.082

3.  Genome-wide Analysis of Salmonella enterica serovar Typhi in Humanized Mice Reveals Key Virulence Features.

Authors:  Joyce E Karlinsey; Taylor A Stepien; Matthew Mayho; Larissa A Singletary; Lacey K Bingham-Ramos; Michael A Brehm; Dale L Greiner; Leonard D Shultz; Larry A Gallagher; Matt Bawn; Robert A Kingsley; Stephen J Libby; Ferric C Fang
Journal:  Cell Host Microbe       Date:  2019-08-22       Impact factor: 21.023

4.  Detection of Vi-negative Salmonella enterica serovar typhi in the peripheral blood of patients with typhoid fever in the Faisalabad region of Pakistan.

Authors:  Stephen Baker; Yasra Sarwar; Hafsa Aziz; Asma Haque; Aamir Ali; Gordon Dougan; John Wain; Abdul Haque
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 5.  Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity.

Authors:  James E Galen; Amanda D Buskirk; Sharon M Tennant; Marcela F Pasetti
Journal:  EcoSal Plus       Date:  2016-11

6.  The O-Antigen Capsule of Salmonella enterica Serovar Typhimurium Facilitates Serum Resistance and Surface Expression of FliC.

Authors:  Joanna M Marshall; John S Gunn
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

Review 7.  Searching for the elusive typhoid diagnostic.

Authors:  Stephen Baker; Michael Favorov; Gordon Dougan
Journal:  BMC Infect Dis       Date:  2010-03-05       Impact factor: 3.090

8.  Clonal expansion and microevolution of quinolone-resistant Salmonella enterica serotype typhi in Vietnam from 1996 to 2004.

Authors:  Thi Anh Hong Le; Laëtitia Fabre; Philippe Roumagnac; Patrick A D Grimont; Maurice R Scavizzi; François-Xavier Weill
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

9.  Evaluation of a simple blood culture amplification and antigen detection method for diagnosis of Salmonella enterica serovar typhi bacteremia.

Authors:  Josée Castonguay-Vanier; Viengmon Davong; Latsanyphone Bouthasavong; Davanh Sengdetka; Manivone Simmalavong; Amphayvanh Seupsavith; David A B Dance; Stephen Baker; Tu Le Thi Phuong; Manivanh Vongsouvath; Paul N Newton
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

10.  Simplest identification, O-specific polysaccharide purification and antigenic evaluation of Salmonella enterica serovar Typhi Vi negative isolate.

Authors:  Muhammad Salman; Aamir Ali; Abdul Jabbar; Yasra Sarwar; Moazur Rahman; Mazhar Iqbal; Abdul Haque
Journal:  EXCLI J       Date:  2015-10-07       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.